search icon

    Market Snapshot

    • S&P Futures

      4,132

    • Dow Futures

      32,804

    • Nasdaq Futures

      13,053.75

    blog search icon

    Vertex Pharmaceuticals Incorporated

    (NASDAQ:VRTX)

    $298.12

    $4.17

    1.42%

    Vertex Pharmaceuticals Incorporated Chart

    VRTX Stock Price Today

    Vertex Pharmaceuticals Incorporated (VRTX) stock rallied over 1.42% intraday to trade at $298.124 a share on NASDAQ. The stock opened with a gain of 9.16% at $288.65 and touched an intraday high of $296.95, rising 3.50% against the last close of $288.03. The stock went to a low of $288.65 during the session.

    Stock Snapshot

    $288.03

    Prev. Close

    71.74 Billion

    Market Cap

    $288.65

    Day Low

    $288.65

    Open

    255.1 Million

    Number of Shares

    $296.95

    Day High

    30.98

    P/E ratio

    9.49

    EPS (TTM)

    32.21

    Cash Flow per Share

    -

    Free Float in %

    37.20

    Book Value

    84,930

    Volume

    Vertex Pharmaceuticals Incorporated Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$288.65$296.95$288.65$291.591,075,603
    2022-08-05$273.11$288.7$272.1$288.032,398,500
    2022-08-04$277.41$278.14$272.93$274.852,034,300
    2022-08-03$276.01$279.37$271.61$275.031,474,300
    2022-08-02$275.82$278.25$273$273.861,006,700
    2022-08-01$279.79$280.72$272.52$273.831,455,900
    2022-07-29$281.8$282.41$275.65$280.411,673,300
    2022-07-28$287.54$288$276.24$280.821,299,200
    2022-07-27$286.27$288.21$280.77$286.991,210,700
    2022-07-26$284.14$290.73$283.7$288.221,534,000

    Contact Details

    50 Northern Avenue
    Boston, MA 02210
    United States

    Webiste:VRTX

    617 341 6100

    Company Information

    Employees-

    Beta0.45

    Sales or Revenue7.95 Billion

    5Y Sales Change34.8%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Vertex Pharmaceuticals Incorporated (VRTX) stock price?

    Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stock price is $298.124 as of the last check on Monday, August 8. During the trading session, VRTX stock reached the peak price of $296.95 while $288.65 was the lowest point it dropped to.

    icon

    VRTX's industry and sector of operation?

    The NASDAQ listed VRTX is part of Biotechnology industry that operates in the broader Health Care sector. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

    icon

    Who are the executives of VRTX?

    Ms. Joy Liu
    Sr. VP & Gen. Counsel
    Dr. Jeffrey Marc Leiden M.D., Ph.D.
    Exec. Chairman
    Dr. Reshma Kewalramani FASN, M.D.
    CEO, Pres & Director
    Mr. Charles F. Wagner Jr.
    Exec. VP & CFO

    icon

    What is the VRTX stock price today?

    VRTX stock traded closed the last session at $291.59, which is $4.174000000000035 or 1.4199693825480644% lower than its previous close of $288.03. VRTX's current trading price is 66.68% lower than its 52-week high of $296.84 where as its distance from 52-week low of 176.36% is -0.97%.

    icon

    How many employees does VRTX have?

    Number of VRTX employees currently stands at -. VRTX operates from 50 Northern Avenue, Boston, MA 02210, United States.

    icon

    Link for VRTX official website?

    Official Webiste of $VRTX is: https://www.vrtx.com

    icon

    How do I contact VRTX?

    VRTX could be contacted at VRTX operates from 50 Northern Avenue, Boston, MA 02210, United States, or at phone #617 341 6100 and can also be accessed through its website.

    icon

    How many shares of VRTX are traded daily?

    VRTX stock volume for the day was 84,930 shares while in the previous session number of VRTX shares traded was 1,075,603 . The average number of VRTX shares traded daily for last 3 months was 1.67 Million.

    icon

    How much did VRTX change today?

    The percentage change in VRTX stock occurred in the recent session was 1.4199693825480644% while the dollar amount for the price change in VRTX stock was $4.174000000000035.

    icon

    What price range VRTX stock been trading in?

    In the recent session, the day high for VRTX stock was $296.95 while the low for VRTX stock touched on the day was $288.65.

    icon

    What is the market cap of VRTX currently?

    The market value of VRTX currently stands at 71.74 Billion with its latest stock price at $298.124 and 255.1 Million of its shares outstanding.